3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Status
Recruiting
4
Unknown
2
Completed
2
Active not recruiting
2
Withdrawn
1
Not yet recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
2
Conditions
Esophageal Squamous Cell Carcinoma
2
Esophageal Neoplasms
1
Interventions
Paclitaxel
8
Radiotherapy
7
Cisplatin
6
pembrolizumab
4
Fluorouracil
4
Surgical Procedures, Operative
3
Radiation
3
Oxaliplatin
3
Levoleucovorin
3
Leucovorin
3
Esophagectomy
3
Drug Therapy
3
Carboplatin
3
lenvatinib
2
durvalumab
2
Taxes
2
TP protocol
2
Radiotherapy, Intensity-Modulated
2
Nivolumab
2
Neoadjuvant Therapy
2
Irinotecan
2
Capecitabine
2
trifluridine tipiracil drug combination
1
tislelizumab
1
palbociclib
1
osimertinib
1
obinutuzumab
1
nedaplatin
1
naptumomab estafenatox
1
futibatinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Active not recruiting
×
Esophageal Squamous Cell Carcinoma
×
TP protocol
×
Clear all
NCT06143748
2026-04-23
EC-CRT-006
Sun Yat-sen University
Phase 2
Active not recruiting
46 enrolled
NCT05520619
2024-11-18
EC-CRT-002
Sun Yat-sen University
Phase 2
Active not recruiting
114 enrolled